Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
National Group Revenue (Post-FY2022)	21.53B	21.28B	19.66B
National Group Revenue (Post-FY2022) Growth	1.20%	8.25%	8.57%
Atlantic Group Revenue (Post-FY2022)	24.91B	24.71B	23.38B
Atlantic Group Revenue (Post-FY2022) Growth	0.79%	5.68%	10.46%
American Group Revenue (Post-FY2022)	26.68B	26.45B	24.67B
American Group Revenue (Post-FY2022) Growth	0.89%	7.20%	10.53%
Corporate & Other Revenue (Post-FY2022)	3.27B	3.17B	2.90B
Corporate & Other Revenue (Post-FY2022) Growth	3.19%	9.28%	-14.18%
Revenue (Total)	76.39B	75.60B	70.60B
Revenue (Total) Growth	1.04%	7.08%	8.67%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
National Group Adjusted EBITDA (Post-FY2022)	5.23B	5.10B	4.39B
National Group Adjusted EBITDA (Post-FY2022) Growth	2.47%	16.19%	9.80%
Atlantic Group Adjusted EBITDA (Post-FY2022)	5.62B	5.64B	4.94B
Atlantic Group Adjusted EBITDA (Post-FY2022) Growth	-0.41%	14.26%	9.93%
American Group Adjusted EBITDA (Post-FY2022)	6.29B	6.30B	5.73B
American Group Adjusted EBITDA (Post-FY2022) Growth	-0.06%	9.90%	10.00%
Corporate & Other Adjusted EBITDA (Post-FY2022)	-1.51B	-1.48B	-1.18B
Operating Income (Other)	-3.66B	-3.60B	-3.34B
Operating Income (Total)	11.97B	11.97B	10.55B
Operating Income (Total) Growth	0.07%	13.44%	9.56%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Number of Hospitals	189.00	190.00	190.00
Number of Hospitals Growth	-0.53%	-	2.15%
Number of Freestanding Outpatient Surgery Centers	119.00	121.00	124.00
Number of Freestanding Outpatient Surgery Centers Growth	-1.65%	-2.42%	-
Number of Licensed Beds	50.46K	50.44K	49.99K
Number of Licensed Beds Growth	0.05%	0.90%	0.80%
Admissions	2.30M	2.30M	2.24M
Admissions Growth	0.17%	2.70%	4.97%
Average Length of Stay (days)	-	4.75	4.84
Average Length of Stay (days) Growth	-	-1.86%	-1.61%
Occupancy Rate	-	73.10%	72.70%

Updated Apr 29, 2026. Data Source: Fiscal.ai.